1. Environmental pollution and disease
Environmental pollution is one of the most urgent public health problems to solve. The World Health Organization (WHO) estimates that 4.2 million deaths per year can be attributed to air pollution, of which 237,000 deaths would be among children under six [
1]. The deterioration of the environment due to the presence of materials and compounds such as carbon dioxide (CO
2), carbon monoxide (CO), nitrogen oxides (NOx), sulfur dioxide (SO
2), volatile organic compounds (VOCs), nitrogen dioxide (NO
2), ozone (O
3), in amounts more significant than natural ones are an anthropogenic phenomenon [
2]. The increase in these compounds is correlated with the rise in chronic degenerative diseases. Of the wide variety of pollutants that affect the quality of life of organisms, particulate matter (PM) stands out, specific microparticles with an aerodynamic diameter of less than 2.5µm (PM2.5) and particles equal or less than 10µm (PM10). Epidemiological studies have shown that the fraction of fine particles of PM2.5 has a more significant impact on health than PM10 [
3]. PM2.5 is generated mainly in combustion processes, which produce carbon particles that, within their structure, may contain nitrates, sulfates, polycyclic aromatic hydrocarbons, and reactive metals such as iron, copper, nickel, zinc, and vanadium [
4]. The physicochemical properties of the particles, such as size, structure, chemical composition, reactivity and solubility, as well as the ability to enter the cell, determine their impact on health and the mechanisms by which PM induces this variety of effects [
5]. It is estimated that O
3 could be responsible for almost 17,000 premature deaths in Europe each year [
6]. Also tropospheric ozone, as well to affecting health, has adverse effects on ecosystems, particularly forests and crops.
The O
3 concentrations are significant because its molecular conformation gives it highly reactive and oxidizing properties, thus producing an oxidizing environment, which when inhaled, alters the balance of the redox balance in the body. Biological systems must maintain the oxidation-reduction balance since a large part of cell signaling depends on redox signals. The loss of oxidation-reduction balance in the organism, caused by excess oxidants, produces a state of oxidative stress. When chronic, this state plays an essential role in developing degenerative diseases, such as autoimmune diseases, cancer, heart disease and diabetes. Still, it also plays a crucial role in developing neurodegenerative immune disorders such as Alzheimer's disease (AD) [
5], Parkinson's disease (PD) [
7], Huntington's disease [
8], amyotrophic lateral sclerosis [
9] and other processes related to pathological aging [
10] (
Figure 1).
2. Environmental pollution and intestine
Mucous membranes are body barriers that are in contact with the environment and constitute different habitats where microbes interact with the host. The digestive tract, respiratory tract, genitourinary tract, and skin are sites where the association with these microorganisms is essential [
11]. The largest population of these microbes is found in the gastrointestinal tract, where one of their functions is to make food and water digested and absorbed into the body [
12,
13]. Moreover, the gut houses most of the mucosa-associated lymphoid tissue in the human body. The intestinal mucosa contains more lymphocytes than any other lymphatic organ [
14]. There is a mutualistic relationship between the gut microbiota and the human host; the intestine provides a niche for microbes to inhabit, while the host benefits from an increase in digestive capacity favored by the microbiota and the generation of metabolites that stimulate the immune system, they also occupy a space within the intestine that prevents accumulation of potentially pathogenic organisms [
15]. Variations in the microbial species and densities of the gut microbiota have been seen to modulate the immune response and susceptibility to different diseases [
16]. In humans, environmental factors such as diet, pollutants, antibiotic treatments, and stress can change the composition of the gut microbiota towards a decrease in the abundance of beneficial bacterial species accompanied by the growth of pathogenic species [
16]. The disturbance in microbial structure and function is known as dysbiosis, which disrupts immune and tissue homeostasis and is associated with various inflammatory diseases inside and outside the gastrointestinal tract [
17]. There are bacterial species of the microbiota in the intestine that can counteract systemic inflammation. The gut microbiota is essential for host digestion and nutrition, as it can generate nutrients from substrates that the host could not otherwise digest. Intestinal microorganisms release short-chain fatty acids (SCFAs) from indigestible dietary fibers, an important energy source for intestinal mucosal cells and essential for modulating immune responses emanating from the intestine [
17]. Therefore, gut bacteria help protect against pathogenic infections through competition, secretion of antimicrobial peptides, stimulation of innate immune cells, development of lymphoid tissue, antibody production and T-cell differentiation [
18]. The gut microbiome has been shown to play a critical role in mediating immune and anti-inflammatory responses at distant sites by releasing and moving microbial metabolites such as SCFAs, cytokines, and hormones into the bloodstream [
16]. The gut mucosa and associated immune system are primed to interact with food, microbiota, potentially harmful antigens, and inflammatory signals from other organs to maintain a fine homeostatic balance and promote an appropriate response, as well to ensure the presence of harmless microbes [
14,
19].
The intestine is exposed to air pollutants through direct or indirect routes. In gas exchange in the lungs, during exhalation, the lung mucus layer can reach the oropharynx and be swallowed and enter the tract. Another mechanism by which contaminants have access to the gastrointestinal tract is through direct ingestion of food and water that contain air pollutants [
20]. Blood flow is important for distributing reactive oxygen species generated in the lungs, secondarily after ozone exposure. Mainly, the gastrointestinal tract is very susceptible to tobacco smoke and exposure to air pollution. These contaminants exacerbate systemic inflammation and cause oxidative damage to gut mucosa and microbiota [
21]. Alterations in intestinal bacterial species, populations and microbial metabolites have been linked to changes in immune responses and inflammation in different organs [
22]. Therefore, the evidence obtained in recent decades strongly suggests that air pollutants, ozone included, generate adverse effects on the digestive tract and that they are participating in the development of Inflammatory Bowel Disease (IBD), Crohn's Disease (CD), appendicitis and Irritable Bowel Syndrome (IBS) [
23,
24], immune diseases, chronic degenerative and neurodegenerative diseases such as Parkinson's and Alzheimer's disease, in which, during their pathophysiology, an environment is generated proinflammatory that affects the rest of the organism (
Figure 2).
3. Intestinal alterations and neurodegeneration
The architecture of the intestinal epithelium is very complex; it is made up of a monolayer of cells connected by different cell junctions, such as tight junctions, gap junctions, and anchor junctions.
The surface of these cells is covered by mucosa, which separates the internal environment from the external one, blocking the passage of substances, which makes it very selective. One of the main functions of these cells is the absorption of nutrients and some electrolytes, which is why it is considered a highly communicated and coordinated semi-permeable barrier to prevent the free passage of certain toxins, antigens, and microbial products. In this way, a balance is generated between these transport mechanisms, the immune system, the metabolites products of the diet, and the intestinal microbiota. An alteration in this dynamic communication would cause a loss in this intestinal barrier, which would generate an imbalance and, therefore, the free passage of some substances and the development of various immune responses [
25]. Some diseases, such as IBD, UC, and CD, whose main characteristic is the presence of a chronic inflammatory process, in which the immune response plays a fundamental role as part of the etiopathogenesis of these diseases, especially the response of T lymphocytes helper 17 (Th17) [
26,
27] and autophagy processes. It is known that patients with IBD have altered levels of cytokines, so they have focused on finding an association between polymorphisms of these cytokines and the relationship between promoters such as tumor necrosis factor-alpha (TNFα) and interleukin 10 (IL-10), as well as the relationships found between IL-1 and its receptor or between the IL-6 or IL-23 receptor [
28]. It has been described that the function of Th17 is to protect the intestinal mucosa and maintain the immune microenvironment, in addition to increasing the inflammatory response through proinflammatory cytokines [
29]; this function is maintained by IL-23 since it acts on the innate response and facilitates the maintenance of Th17 cells [
30]. The cellular organization of the intestine that allows permeability maintenance can be compromised and facilitate the development of certain diseases. Proteins associated with granule exocytosis pathways in Paneth cells [
31] and by transcription factors, such as XBP1, are known to respond to endoplasmic reticulum stress and are required for maintenance of the secretory cells [
32], both mechanisms generate more susceptibility to intestinal inflammation, generating the loss of intestinal permeability (
Figure 3).
4. Intestinal permeability and neurodegeneration
Paneth cells, participating in granule exocytosis pathways, have the function of producing antimicrobial peptides that control populations of bacteria harmful to the intestinal microbiota [
33]. There is evidence that endotoxins, which are lipopolysaccharides (LPS) components of the cell wall of Gram-negative bacteria, generate a proinflammatory response mediated by TNFα, IL-1β or nitric oxide (NO) (
Figure 3) [
34]. In a mouse model, inhalation of low levels of endotoxin after exposure to ozone promoted an increase in various factors such as IL-1β, IL-1α, and IL-6, potentiating lung lesions in mice [
35]. In addition, in clinical studies, Angelico Mendy et al. 2019 concluded a synergistic association between co-exposure to endotoxin and environmental contamination, increasing the recurrence of hospitalization due to asthma attacks in children [
36].
Recent studies point to the relationship between intestinal microbiota and some neurodegenerative diseases. The brain-gut-microbiota axis is a bidirectional system that allows metabolic, immune, endocrine, and neuronal signaling [
37] in both directions. Some evidence links endotoxins directly to neurodegeneration through systemic inflammation and microglia activation. Systemic LPS promotes IL-1β activation of microglia, chemokines, IL-6, and acute cognitive loss in mice [
38]. LPS injected intraperitoneally promotes the accumulation of Aβ 1-42 in the hippocampus and cerebral cortex in mice, generating neuronal pyroptosis [
39], hyperphosphorylation of the tau protein [
40] and an increase in α-synuclein [
41]. On the other hand, Alzheimer's disease has been characterized mainly as a disease in which extracellular deposits of the β-amyloid (Aβ) protein form neuritic plaques, which eventually lead to the intracellular accumulation of abnormal tau proteins and the subsequent formation of neurofibrillary tangles [
42,
43]. Molecular mimicry is a concept that allows us to explain how certain similarities occur in the tertiary structure of an exogenous and pathogenic protein and some human proteins [
44]. This hypothesis reminds us of the formation of prions in the central nervous system and the generation of certain diseases. Particularly in Parkinson's disease, patients have a recurrent history of gastrointestinal dysfunctions before diagnosis [
45]. Various studies have generated the "seed" of α-synuclein protein that recruits other endogenous α-synuclein proteins and subsequently becomes insoluble, hyperphosphorylated, and ubiquitinated pathological proteins [
46]. Different models of α-synuclein "seeding" demonstrated the induction of pathological α-synuclein from the peripheral nervous system to the central nervous system following the injection of intramuscular α-synuclein in transgenic mice [
47].
Some studies show how some species of bacteria produce extracellular amyloid protein fibers, which are helpful for environmental protection and surface adherence [
48]. This protein, formed from the CsgG protein, allows a flow of macromolecules since it forms a functional nanopore [
49]. Through a complex transport system, this system creates a "curli" fiber within the system [
50]. Cellular pathways activated by bacterial amyloid in neurodegeneration processes include the TLR 2/1, CD14, and NFκB system [
51].
Therefore, the structural complexity of the intestinal barrier is compromised when bowel permeability fails. The mechanisms underlying this mechanism range from a loss in the transport of granules, a decrease in the mucus layer, changes in the intestinal microbiota, and an alteration in the production of specific metabolites, such as LPS and proteins, such as α-synuclein or amyloid protein. All these changes activate signaling pathways that increase free radicals, as well as the activation of antioxidant and immune response systems, which, when they lose regulation, establishes a chronic state of oxidative stress and loss of regulation of the inflammatory response, establishing a vicious circle, which is present in chronic-degenerative diseases.
5. Parkinson's disease and intestine
Parkinson's disease (PD) is a neurodegenerative disease with a chronic state of oxidative stress and loss of regulation of the inflammatory response. These alterations give rise to oxidation of dopamine and formation of metabolites of this neurotransmitter, such as dopamine quinones [
52]. Neuromelanin is found in catecholaminergic neurons of the substantia nigra pars compacta and locus coeruleus and protects neurons from oxidation processes. Loss of neuromelanin and subsequent depigmentation of these brain regions is a hallmark of PD. There is evidence to suggest that neuromelanin-abundant substantia nigra pars compacta dopaminergic neurons are more sensitive to cell death [
53,
54]. It has been proposed that there is a bidirectional communication of the brain-gut axis since there is evidence of accumulation of α-synuclein outside the brain, the abnormal accumulation of α-synuclein in the esophagus and the submucosal in the myenteric plexus and nerve fibers in the enteric nervous system has also been demonstrated [
55].
It has been described alterations in gastrointestinal tract may precede changes in the brain; among these are dysphagia, increased salivation, delayed gastric emptying, and constipation [
56,
57], also alterations in the microbiota and abnormal accumulation of α-synuclein in the gastrointestinal system. The intestine has an essential role as a barrier [
58] since it prevents the release of food antigens and inflammatory bacteria, preventing them from entering the circulation; however, when the barrier is altered, it becomes very permeable, releasing it into the torrent blood proinflammatory molecules [
59] which causes the lymphoid follicles of the mucosa to become activated; T and B lymphocytes found in Peyer's patches adjacent to M cells proliferate as a process of stimulation by a specific antigen, releasing into the bloodstream, from there, they migrate to the lamina propria, and this is where the lymphocytes B are transformed into plasma cells, which produce specific secretory IgA against different antigens. IgA produced in the mucosa does not activate the complement pathway and does not cause inflammation [
60]. Also, an inflammatory process is induced when foods rich in antigens from pathogenic organisms such as bacteria are ingested. Matthew Stephens and Pierre-Yves von der Weid (2020) demonstrated that LPS from specific species of the bacteria
S. macescens,
P. aeruginosa,
K. pnemoniae, and
S. enterica could differentially modulate TNFα through factor activation—core kB (NFkB) [
61]. The intestine can distinguish between its own microbiota and pathogenic organisms. It is known that alterations between resident and pathogenic bacteria lead to an immune imbalance producing inflammation. It is accompanied by a loss of control of intestinal permeability that allows the release of bacterial LPS that reach the enteric nervous system, maintaining an inflammatory state as occurs in CD and PD. Otherwise, it has been observed that patients with Parkinson's disease have increased permeability in the colon (
Figure 4), contributing to the systemic inflammatory process in patients with said disease.
6. Alzheimer's disease and intestine
One of the characteristics of Alzheimer's disease is the extracellular accumulation of β-amyloid peptide (βA), mainly the βA1-42 isoform, which forms plaques in various regions of the cerebral cortex and intracellular neurofibrillary tangles of hyperphosphorylated tau protein in the hippocampus, medial temporal lobe, isocortical temporal, parietal areas, and frontal lobes, producing loss of regulation of neuronal metabolism such as glutamatergic, cholinergic, and GABAergic neurotransmission [
62]. Oxidative stress causes a change in the conformation of this peptide, making it more insoluble and impossible to eliminate [
63]. The decrease in its clearance of βA leads to the loss of neuronal homeostasis [
64]. However, one of the roles that βA plays in "normal" functioning in the brain is associated with glucose metabolism, specifically in the internalization of glucose [
65]. Glucose uptake in neurons is mainly carried out by the glucose transporter 3 (GLUT3) [
66]. In regions such as the hippocampus, one of the main areas compromised in AD, transport is carried out through the expression of GLUT4 in neurons by binding insulin or βA1-40 to the insulin receptor. Which activates the PI3K/Akt pathway, whose anti-apoptotic processes promote neuronal survival, as well as receptor translocation [
65]. The pathogenesis associated with AD involves decreased hippocampal volume, cerebral hypoxia, neuroinflammation and neuronal ischemic events, which is associated with the gradual loss of episodic memory in patients [
64]. It has been observed that the oxidative damage generated by the increase in reactive oxygen species (ROS) due to exposure to O
3 influences the density and functionality of neurons and glia in the hippocampus, reflecting the loss of synapses and with it a deficit in the functionality of the hippocampus, which could be reflected in the decrease in attention or short-term memory [
67,
68,
69]. Studies in rats exposed to O
3 found that the increase in ROS is directly related to the rise in the levels of peroxidized lipids and proteins, which promote apoptosis in the hippocampus [
70]; specifically in the CA1, CA3, and dentate gyrus regions; increasing the production and accumulation of the βA1-42 peptide in cells in the dentate gyrus [
71].
The increase in lipids and proteins oxidized by ROS in these hippocampal regions promotes the expression of βA1-42, which results from the oxidation of the sulfhydryl radical of βA1-40, specifically methionine at position 35, promoting a more significant interaction between βA and the unsaturation of the lipid chains of the membrane of neurons, initiating lipid peroxidation, generating highly reactive products such as 4-hydroxy-2-nonenal (4HNE) and acrolein, which amplifies the oxidative effect of βA1 -42 [
72], this causes accumulation of βA1-42, generating oligomers, which, when bound to IR, prevent its phosphorylation, decreasing glucose metabolism and inactivating the PI3K/Akt pathway, compromising survival neuron of the hippocampus [
65].
Besides this, to try to eliminate these βA adducts, astrocytes and microglia, by binding to βA activate the MyD88 pathway through their toll-like 4 receptors (TLR4), promoting the expression of the receptor for tumor necrosis factor associated with factor 6 (TRAF6) and the CD33 receptor in the hippocampus and the cerebral cortex, causing neuroinflammation due to overexpression of glial fibrillary acidic protein (GFAP), generating astrogliosis [
73,
74], as well as the increase in NFkB which promotes the expression of proinflammatory cytokines such as IL-1β, IL-6, and TNFα, atrophying hippocampal communication between neurons and the glia [
70].
In murine models, it has been shown that exposure to O
3 promotes the production of NO, and this, in the presence of superoxide ion, generates the peroxynitrite ion (ONOO-). These highly oxidizing species together induce neurotoxicity in the hippocampus and cortical areas. The generation of NO in microglia causes high oxidation of lipids, proteins, and genetic material that favors the activation of different signaling pathways such as the Janus kinase complex (JAK's), protein tyrosine kinase (TK's), protein kinase C (PKC), mitogen-activated protein kinases (MAPK's), as well as NFκB and activator protein 1 (AP-1), prooxidant enzymes such as inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and lipoxygenase 5 (LPO-5) [
75]. In addition to the activation of these pathways, there is also an expression of proinflammatory cytokines such as IL-6, IL-1α, IL1β, TNFα factor and granulocyte-macrophage colony-stimulating factor that stimulate a state of neuronal stress. This state is mediated by high levels of ROS and inflammatory mediators, resulting in neuronal death and expression of AD pathogenesis [
64,
75]. RAMAN spectrometry studies show that repeated exposure to O
3 causes conformational changes in the secondary amino acids of the βA1-40 peptide, taking it from an alpha helix conformation to a beta-sheet structure, which is insoluble and impossible to eliminate [
63]. Therefore, in urbanized cities such as ours, exposure to O
3 from our childhood can affect our learning and even be a promoter of the oxidation of proteins, lipids, and genetic material that in our adult life are related to the overexpression of the βA1-42 peptide and neurofibrillary tangles that could lead to the development of Alzheimer's disease.
Additionally, an increase in cholesterol ester hydroperoxides (CE-OOH) has been observed in patients with AD. These hydroperoxides are products of lipoprotein oxidation, such as chylomicrons, high-density lipoproteins (HDL), and intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL), specifically those whose structure includes apolipoproteins AI, B48/B100, D, E, and J/clusterin, which participate in lipoprotein binding to the anchoring sites associated with ATP, in lipid transport, in cholesterol metabolism, as well as defense against oxidative damage, increasing their levels in plasma, promoting a state of oxidized hypercholesterolemia [
76], which increases the expression of proinflammatory cytokines as well as inducing cell damage and due to this increase in peroxidized lipids the RedOx balance is compromised. Therefore, antioxidant proteins such as paraoxonases (PON) protect lipoproteins from oxidative stress, reducing the damage caused by ROS [
77]. However, it has been observed that in patients and mouse models of AD, PON1, and PON3, located in the systemic circulation, and PON2, located throughout the intestinal tract from the duodenum to the distal colon, in different subcellular compartments such as mitochondria, lysosomes, and microsomes decrease their activity, promoting intestinal inflammation [
78]. Therefore, in urbanized cities like ours, exposure to O
3 from our childhood can have repercussions on our learning and even be a promoter of the oxidation of genetic material, proteins, and lipids, as well as the decrease in our antioxidant proteins that protect us from damage associated with oxidation; which in our adult life can be related to intestinal problems associated with an increase in plasma cholesterol and the overexpression of the βA1-42 peptide and neurofibrillary tangles that could lead to the development of Alzheimer's disease.
Figure 5.
Exposure to O3 increases the production of ROS, which leads to the development of inflammatory bowel diseases associated with the increase of cytokines IL-6, IL-1β and TNFα, as well as the activation of TH1, TH17 and NK cells responsible for cell maintenance; however, the increase in ROS, as well as the decrease in antioxidant defenses, limits the function of lymphocyte cells, generating peroxidized lipid adducts such as CE-OOH and 4HNE at the systemic level, decreasing antioxidant defenses, causing polypeptides such as βA to oxidize and generating oligomers of βA1-42, which interrupt the internalization of glucose, causing survival pathways such as PI3K/AKT to be inhibited, causing neuronal cells to atrophy, which causes astrocytes and microglia to be activated, releasing proinflammatory cytokines causing neuroinflammation, which chronically leads to neurodegeneration of neurons in the hippocampus and cortical areas that is pathologically associated with gradual loss of movement and memory, finally It is currently believed that discrete degenerative processes at the beginning of AD such as the deposition of highly insoluble βA and the accumulation of tau proteins-damage neurons and provide clear inflammatory stimuli to local microglia, and the hippocampus.
Figure 5.
Exposure to O3 increases the production of ROS, which leads to the development of inflammatory bowel diseases associated with the increase of cytokines IL-6, IL-1β and TNFα, as well as the activation of TH1, TH17 and NK cells responsible for cell maintenance; however, the increase in ROS, as well as the decrease in antioxidant defenses, limits the function of lymphocyte cells, generating peroxidized lipid adducts such as CE-OOH and 4HNE at the systemic level, decreasing antioxidant defenses, causing polypeptides such as βA to oxidize and generating oligomers of βA1-42, which interrupt the internalization of glucose, causing survival pathways such as PI3K/AKT to be inhibited, causing neuronal cells to atrophy, which causes astrocytes and microglia to be activated, releasing proinflammatory cytokines causing neuroinflammation, which chronically leads to neurodegeneration of neurons in the hippocampus and cortical areas that is pathologically associated with gradual loss of movement and memory, finally It is currently believed that discrete degenerative processes at the beginning of AD such as the deposition of highly insoluble βA and the accumulation of tau proteins-damage neurons and provide clear inflammatory stimuli to local microglia, and the hippocampus.

7. Discussion
It has been widely demonstrated that environmental pollution by ozone produces a chronic state of oxidative stress. Increase in ROS secondary to ozone inhalation leads to the loss of regulation of cell functions. The oxidation-reduction processes that regulate cell activity are one of the first signals to appear during evolution. Therefore, they are central to the physiological organization that allows proper cell function. ROS regulate many cellular signals (metabolic, endocrine, reproductive, etc.) and particularly of the immune system. The inflammatory response is key in cell defense and repair, it is a self-limited response and modulated by redox signaling. Hence, the redox balance is necessary for the immune response to maintain its function. However, repeated exposure to environmental pollution by ozone (at low doses) causes a slight increase in ROS, and the antioxidant defenses do not respond adequately. The gradual increase in ROS and the inability of the antioxidant systems induce a chronic state of oxidative stress that leads to a loss of regulation of the inflammatory response, as occurs in non-infectious chronic-degenerative diseases. The chronic state of oxidative stress is an epiphenomenon that affects the entire organism. However, depending on the antioxidant capacity and other factors, whether the genetic or previous presence of disease, the target organ will be more compromised than the others [
79,
80]. There is a clear association between the gastrointestinal system and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Also, there are intrinsic alterations of the intestine in the face of oxidative stress caused by environmental pollution by ozone. The response of the duodenum and colon seems to be important for gastrointestinal pathologies. Which can be explained as follows:
1) Oxidative stress causes alterations in the intestinal wall, altering permeability and allowing the passage of high molecular weight molecules that will ultimately stimulate the immune system, causing inflammation and disease.
2) Oxidative stress acts on the intestinal microbiome, changing its balance and favoring microorganisms whose metabolism causes toxic molecules that contribute to further increased inflammation and forming a vicious circle between loss of regulation of the inflammatory response, increase intestinal permeability, harmful change of intestinal microorganisms and alteration of the immune response.
Association between gastrointestinal alterations and non-communicable chronic degenerative diseases share a series of characteristics such as the chronic state of oxidative stress, loss of regulation of the immune response, alteration in permeability of both the blood-brain and intestinal barriers allowing passage of high molecular weight substances, formation of toxic metabolites both by the intestinal bacteria as well ROS and accumulation of insoluble proteins such as α-synuclein, amyloid peptides, etc.